Brolucizumab: Will it Make a Differance

Related

• 

  Silicone Oil (SO) Microdroplets in Repackaged Bevacizumab Syringes: Identification, Quantification, and Strategies For Reducing Clincal Impact

  John D Pitcher, MD

  On Demand Cases, Courses, and Papers

  2017

• 

  Two-Year Results of an Ongoing Phase 1b/2 Open-Label Clinical Trial of AU-011 for the Primary Treatment of Small to Medium Choroidal Melanoma

  Amy C. Schefler, MD FACS FASRS

  Annual Meeting Talks

  2019

• 

  Journal Club with Dr. Ferhina Ali and Dr. Daniel Chao Discussing Caffeine and Beta Blockers for Vitreoretinal Surgeons, Cost-Savings with Intravitreal Bevacizumab, and more

  Jayanth Sridhar, MD

  Daniel L Chao, MD, PhD

  Ferhina S Ali, MD, MPH

  Member Podcasts

  2020